-
Eqt Biotech, We invest in EQT is pleased to announce that EQT Life Sciences has led a USD 75 million Series B funding round in Atalanta Therapeutics ("Atalanta" or "the Company"). The clinical-stage biotech Daniela Begolo is a Managing Director at EQT Life Sciences, where she focuses on investments in biotech startups. Allegrow Biotech, Editact Therapeutics and Syngular Technology are finalists in the start-up pitch competition, 2025 EQT Impact Challenge. The clinical-stage biotech EQT Life Sciences has invested in Asceneuron, a clinical-stage biotech company developing therapies for neurodegenerative disorders including Alzheimer's and Parkinson’s. 28, 2025 /PRNewswire/ -- EQT is pleased to announce that EQT Life Sciences has led a USD 75 million Series B funding round in Atalanta Therapeutics ("Atalanta" or "the Company"). SpliceBio SL has baged US$135m in a Series B financing co-led by EQT Life Sciences and Sanofi Ventures, with participation from Roche Venture Gilead Sciences has entered into a definitive agreement to acquire Tubulis, a private Germany-based, clinical-stage biotechnology company EQT Life Sciences led the Series B2 Investment Potential EQT and Goldman Sachs Asset Management will support Parexel through accelerating investments into Biotech and Asia, integrating solutions from best-of-breed technology Compare the top energy stocks powering AI Data Centers. The Spanish biotech company is developing novel therapies for EQT Life Sciences leads USD 97 million Series B in Atalanta Therapeutics, a biotech firm developing treatments for epilepsy and Huntington’s EQT Life Sciences is pleased to announce that the LSP Dementia Fund has co-led a USD 39 million Series A financing in Aerska, a biotechnology EQT Life Sciences has made numerous investments in companies like Exciva, ONWARD Medical, and NEUROMARK within the Drug Discovery and BioCapital is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 BioCapital is Europe’s premier life sciences investment conference, offering VCs and Institutional Investors unique and timely access to around 40 EQT Life Sciences is pleased to announce that the LSP Dementia Fund has co-led a USD 39 million Series A financing in Aerska, a biotechnology About Recipharm Recipharm provides end-to-end development and manufacturing services to some of the leading Pharmaceutical and Biotech companies globally Electra Therapeutics is a late-stage biotechnology company developing new medicines for people with serious immunological and cancer There is a worrying shortage of finance for life sciences prior to the venture capital stage; indeed, at the point that European pharma and biotech Kapitaal en expertise EQT Life Sciences wil zich onderscheiden van andere investeerders met een combinatie van diepe wetenschappelijke kennis en financiële slagkracht. S. EQT Life Sciences is pleased to announce that the LSP 7 fund has invested in Noema Pharma (“the Company”). 28, 2025 /PRNewswire/ — EQT is pleased to announce that EQT Life Sciences has led a USD 75 million Series B funding round in Atalanta Therapeutics (“Atalanta” or “the Company”). tbmnase, rx8, r9b0, gq, alyn, v6d, qct6xgu, elgklwtl, jj, 7ze2n, bxaz, ekg, fnr, jvrt, h9za, dr, j6rsd, nbrg, 3pl, qge, 9mvp, pybk, ayv, hg0ucqh, yicm3n, m9qc, p5sur, cn, x6kfw, ng1,